Merck Digital Sciences Studio

Merck Digital Sciences Studio

Newark, New Jerseymds.studio

Overview

Merck Digital Sciences Studio (MDSS) is a startup accelerator program focused on supporting and investing in early-stage companies developing innovative digital technologies for drug discovery and development. It is a collaboration between Merck, the New Jersey Innovation Institute (NJII), Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, with technology support from Microsoft for Startups. The studio provides mentorship, training, and direct investment to startups, with a focus on those utilizing artificial intelligence (AI) and machine learning (ML). The program operates cohorts in the US and Canada, offering funding via SAFE agreements to participating companies.

Portfolio Companies

8

Website

mds.studio

Investments

CompanyDateStageLead
NuvoBioMar 2026AcceleratorLead
9Bio TherapeuticsJun 2025AcceleratorLead
WhelixMar 2025Pre SeedCo-investor
DANNCE.aiNov 2024Pre SeedCo-investor
Pepper BioNov 2023SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNewark, New Jersey
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.